MedPath

Diagnostic Photonics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Suspended
Conditions
Breast Cancer
First Posted Date
2014-12-09
Last Posted Date
2019-07-18
Lead Sponsor
Diagnostic Photonics, Inc.
Target Recruit Count
50
Registration Number
NCT02313116
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Completed
Conditions
Breast Cancer
First Posted Date
2012-10-04
Last Posted Date
2015-01-06
Lead Sponsor
Diagnostic Photonics, Inc.
Target Recruit Count
50
Registration Number
NCT01699867
Locations
🇺🇸

Anne Arundel Medical Center, Annapolis, Maryland, United States

🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Real Time Optical Coherence Tomography (OCT) of Human Tissue

Terminated
Conditions
Breast Cancer
First Posted Date
2012-01-10
Last Posted Date
2019-07-26
Lead Sponsor
Diagnostic Photonics, Inc.
Target Recruit Count
5
Registration Number
NCT01506700
Locations
🇺🇸

Carle Foundation Hospital, Urbana, Illinois, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.